[1]
A. S. Lonsdorf, “Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases”, Acta Derm Venereol, vol. 104, p. adv13381, Feb. 2024.